A carregar...

Payers’ Dilemma: Looming Costs For Chronic Conditions

Biotech products for chronic conditions will be coming with regularity in the next few years, and these represent both a clinical opportunity and a financial challenge for health plans. So far, few payers have figured out how to make such treatments available without breaking the bank. The challenge...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: HERSKOVITZ, STEPHEN
Formato: Artigo
Idioma:Inglês
Publicado em: BioCommunications LLC 2005
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3564357/
https://ncbi.nlm.nih.gov/pubmed/23393448
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!